Skip to content

Carotid Artery Stent Implantation in the Treatment of Vulnerable Plaque

A Controlled Clinical Study of Carotid Artery Stent Implantation in the Treatment of Vulnerable Plaque

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05524207
Acronym
CASTLE
Enrollment
100
Registered
2022-09-01
Start date
2022-01-01
Completion date
2024-12-30
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Plaque, Carotid Stenosis, Stent Embolisation

Keywords

carotid artery stenosis, vulnerable plague, carotid stenting

Brief summary

To investigate the efficacy and safety of carotid stenting for vulnerable carotid plaques. All patients with carotid artery stenosis underwent carotid arterial contrast-enhanced ultrasonography before operation. According to the examination results, they were divided into two groups: vulnerable plaque group and stable plaque group. The incidence of perioperative stroke events in the two groups was compared. The incidence of stroke events in the two groups within 1 year was compared.

Detailed description

1. To enroll 100 cases of patients suffering from carotid artery stenosis。the investigators perform contrast enhanced ultrasound on patients for identifying the vulnerable plagues 2. The investigators divide patients into the stable group and the vulnerable group based on the results of CEUS inspection. 3. All patients undergo carotid stent. To analysis the incidence of postoperative complications such as stroke and mortality within 30 days and to compare the differences between the two groups.

Interventions

PROCEDUREcarotid artery stenting

Implantation of stents at the site of carotid artery stenosis for the treatment of carotid plaque with severe stenosis

Sponsors

Beijing Tsinghua Chang Gung Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* The patients with ischemic symptom whose carotid stenosis were more than 50% * The patients without ischemic symptom whose carotid stenosis were more than 70%

Exclusion criteria

* • Confirmed with severe intracranial vascular lesions * Suffering from the large area cerebral infarction or critical stroke sequela * Restenosis after CEA or CAS * Suffering from severe coronary heart disease, respiratory failure,the hypertension difficult to controled * Patients with malignant tumor or expected life \< 2 years

Design outcomes

Primary

MeasureTime frameDescription
Perioperative 30-day stroke rate30 daysTo determine whether there is a new cerebral infarction by postoperative re-examination of brain MRI and preoperative brain MRI

Secondary

MeasureTime frameDescription
1-year stroke rate after surgery1 yearStroke rate in ipsilateral carotid artery blood supply area within 1 year after operation

Countries

China

Contacts

Primary Contactkeqiang zhao, M.D.
zkqiang@139.com0086-56119121
Backup Contactweiwei wu, M.D.
0086-56118899

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026